February 22, 2019 - Press notes
Researchers from the Hospital del Mar and Hospital del Mar Medical Research Institute (IMIM) have led a study verifying the importance of the presence of a specific type of lymphocyte in the success of anti-tumour treatments in patients with HER2-positive breast cancer.
This is the first time that the role of these immune system cells in treatment response has been verified with patient samples. The role HLA molecules play in obtaining good results has also been determined.
This work leads the way to finding new methods for reinforcing both existing treatments and those in a trial phase, including the possibility of transplanting NK cells from healthy patients into cancer sufferers. The study has been published in the journal Clinical Cancer Research
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2026 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
